BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Baxter to Host Fourth-Quarter 2024 Financial Results Conference Call for Investors

  January 23, 2025

   · 

  1 min read
• Press Releases

  ZIVO Bioscience to Present at The Microcap Conference 2025

  January 23, 2025

   · 

  1 min read
• Press Releases

  Varex Schedules First Quarter Fiscal Year 2025 Earnings Release and Conference Call

  January 23, 2025

   · 

  1 min read
• Press Releases

  Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.

  January 23, 2025

   · 

  5 min read
• Press Releases

  BlossomHill Therapeutics Doses Patients in the First Cohort of the Phase 1/2 SOLARA Clinical Trial of BH-30643 for EGFR- and HER2-Mutated Non-Small Cell Lung Cancer

  January 23, 2025

   · 

  2 min read
• Press Releases

  Arrowhead Pharmaceuticals to Webcast Fiscal 2025 First Quarter Results

  January 23, 2025

   · 

  4 min read
• 

  Career Advice

  M&A Survival Guide: 6 Tips for Making the Most of a Stressful Situation

  M&As are stressful for multiple reasons, including role changes and getting laid off when staffs combine. Two talent experts share tips for navigating the transition period of your company’s merger or acquisition.

  January 23, 2025

   · 

  6 min read

   · 

  Angela Gabriel
• Press Releases

  STERIS to Host a Conference Call for Fiscal 2025 Third Quarter Financial Results on February 6, 2025

  January 23, 2025

   · 

  7 min read
• Press Releases

  Data Published Today in the New England Journal of Medicine Demonstrates Anthos Therapeutics’ novel Factor XI inhibitor, Abelacimab 150mg, Reduced Major or Clinically Relevant Non-Major Bleeding by 62% Compared to Rivaroxaban (Xarelto) in Patients with Atrial Fibrillation

  January 23, 2025

   · 

  7 min read
• Press Releases

  Aurora Spine Announces Leadership Promotions: Matt Paxton, Executive Vice President of Sales and Katelyn Sims, Area Vice President of Commercialization and Key Accounts

  January 23, 2025

   · 

  4 min read